BACKGROUND: Radiation therapy (RT) is indicated for the treatment of local-regionally advanced breast cancer (BCa). HYPOTHESIS: We hypothesized that black and Hispanic patients with local-regionally advanced BCa would receive lower rates of RT than their white counterparts. METHODS: The Surveillance Epidemiology and End Results database was used to identify white, black, Hispanic, and Asian patients with invasive BCa and ≥10 metastatic lymph nodes diagnosed between 1988 and 2005. Univariate and multivariate logistic regression evaluated the relationship of race/ethnicity with use of RT. Multivariate models stratified for those undergoing mastectomy or lumpectomy. RESULTS: Entry criteria were met by 12,653 patients. Approximately half of the patients did not receive RT. Most patients were white (72%); the remainder were Hispanic (10.4%), black (10.3%), and Asian (7.3%). On univariate analysis, Hispanics (odd ratio [OR] 0.89; 95% confidence interval [CI], 0.79-1.00) and blacks (OR 0.79; 95% CI, 0.70-0.89) were less likely to receive RT than whites. On multivariate analysis, blacks (OR 0.76; 95% CI, 0.67-0.86) and Hispanics (OR 0.80; 95% CI, 0.70-0.90) were less likely than whites to receive RT. Disparities persisted for blacks (OR 0.74; 95% CI, 0.64-0.85) and Hispanics (OR 0.77; 95% CI, 0.67-0.89) who received mastectomy, but not for those who received lumpectomy. CONCLUSIONS: Many patients with local-regionally advanced BCa do not receive RT. Blacks and Hispanics were less likely than whites to receive RT. This disparity was noted predominately in patients who received mastectomy. Future efforts at improving rates of RT are warranted. Efforts at eliminating racial/ethnic disparities should focus on black and Hispanic candidates for postmastectomy RT.
BACKGROUND: Radiation therapy (RT) is indicated for the treatment of local-regionally advanced breast cancer (BCa). HYPOTHESIS: We hypothesized that black and Hispanic patients with local-regionally advanced BCa would receive lower rates of RT than their white counterparts. METHODS: The Surveillance Epidemiology and End Results database was used to identify white, black, Hispanic, and Asian patients with invasive BCa and ≥10 metastatic lymph nodes diagnosed between 1988 and 2005. Univariate and multivariate logistic regression evaluated the relationship of race/ethnicity with use of RT. Multivariate models stratified for those undergoing mastectomy or lumpectomy. RESULTS: Entry criteria were met by 12,653 patients. Approximately half of the patients did not receive RT. Most patients were white (72%); the remainder were Hispanic (10.4%), black (10.3%), and Asian (7.3%). On univariate analysis, Hispanics (odd ratio [OR] 0.89; 95% confidence interval [CI], 0.79-1.00) and blacks (OR 0.79; 95% CI, 0.70-0.89) were less likely to receive RT than whites. On multivariate analysis, blacks (OR 0.76; 95% CI, 0.67-0.86) and Hispanics (OR 0.80; 95% CI, 0.70-0.90) were less likely than whites to receive RT. Disparities persisted for blacks (OR 0.74; 95% CI, 0.64-0.85) and Hispanics (OR 0.77; 95% CI, 0.67-0.89) who received mastectomy, but not for those who received lumpectomy. CONCLUSIONS: Many patients with local-regionally advanced BCa do not receive RT. Blacks and Hispanics were less likely than whites to receive RT. This disparity was noted predominately in patients who received mastectomy. Future efforts at improving rates of RT are warranted. Efforts at eliminating racial/ethnic disparities should focus on black and Hispanic candidates for postmastectomy RT.
Authors: J G Canto; J J Allison; C I Kiefe; C Fincher; R Farmer; P Sekar; S Person; N W Weissman Journal: N Engl J Med Date: 2000-04-13 Impact factor: 91.245
Authors: Caprice C Greenberg; Eric C Schneider; Stuart R Lipsitz; Clifford Y Ko; Jennifer L Malin; Arnold M Epstein; Jane C Weeks; Katherine L Kahn Journal: J Am Coll Surg Date: 2008-02-01 Impact factor: 6.113
Authors: Mary Jo Lund; Otis P Brawley; Kevin C Ward; John L Young; Sheryl S G Gabram; J William Eley Journal: Breast Cancer Res Treat Date: 2007-07-21 Impact factor: 4.872
Authors: Ya-Chen Tina Shih; Ying Xu; Mariana Chavez-MacGregor; B Ashleigh Guadagnolo; Benjamin D Smith; Sharon H Giordano Journal: JAMA Oncol Date: 2017-10-01 Impact factor: 31.777
Authors: Adil S Akthar; Christopher D Hellekson; Sabha Ganai; Olwen M Hahn; Ronald J Maggiore; Ezra E Cohen; Mitchell C Posner; Steven J Chmura; Andrew R Howard; Daniel W Golden Journal: J Cancer Educ Date: 2018-06 Impact factor: 2.037
Authors: Reshma Jagsi; Paul Abrahamse; Sarah T Hawley; John J Graff; Ann S Hamilton; Steven J Katz Journal: Cancer Date: 2011-06-29 Impact factor: 6.860
Authors: Jill K Schinkel; Shelia Hoar Zahm; Ismail Jatoi; Katherine A McGlynn; Christopher Gallagher; Catherine Schairer; Craig D Shriver; Kangmin Zhu Journal: Cancer Causes Control Date: 2014-05-17 Impact factor: 2.506
Authors: Leticia M Nogueira; Helmneh M Sineshaw; Ahmedin Jemal; Craig E Pollack; Jason A Efstathiou; K Robin Yabroff Journal: JAMA Netw Open Date: 2022-04-01
Authors: Shearwood McClelland; Brandi R Page; Jerry J Jaboin; Christina H Chapman; Curtiland Deville; Charles R Thomas Journal: Adv Radiat Oncol Date: 2017-08-03
Authors: William W Chance; Karen J Ortiz-Ortiz; Kai-Ping Liao; Diego E Zavala Zegarra; Michael C Stauder; Sharon H Giordano; Guillermo Tortolero-Luna; B Ashleigh Guadagnolo Journal: J Glob Oncol Date: 2017-05-11